Liu W K, Bousfield G R, Moore W T, Ward D N
Endocrinology. 1985 Apr;116(4):1454-9. doi: 10.1210/endo-116-4-1454.
The FSH activity in equine (e) FSH, eLH, eCG, and ovine LH were examined and compared to that in the standard reference preparation NIH FSH-S13 by three types of assay: the FSH radioreceptor assay with rat testicular homogenate and the stimulation of plasminogen activator production and steroidogenic activity in granulosa cells from diethylstilbestrol (DES)- or eCG-primed donor rats. The difference in the two types of granulosa cells was that the eCG-primed cells have already acquired significant aromatase activity. With the exception of oLH, which showed very little FSH activity (approximately 0.03-0.08 X NIH FSH-S13) throughout the three assays, the equine gonadotropins exhibited great variations in activity with respect to each assay. eFSH, the most active molecule in these assays, had an activity of 44 X NIH FSH-S13 in the receptor binding assay, 8.75 X NIH FSH-S13 in plasminogen activator production, and 4-5 X NIH FSH-S13 in steroid production when assayed in the DES-primed granulosa cells. In the eCG-primed cells, eFSH showed an activity of 4.2 X NIH FSH-S13 in plasminogen activator production and 8.2 X NIH FSH-S13 in progesterone production. eLH had an activity of 10 X NIH FSH-S13 in FSH radioreceptor assay, but showed very little activity and behaved like oLH in stimulation of the cellular responses of DES-primed granulosa cells. However, when eLH was assayed in the eCG-primed cells, it did show stimulating activity with respect to the production of plasminogen activator and progesterone; however, the dose-response curves were not parallel to those of eFSH and eCG. eCG had much less FSH receptor-binding activity (0.29 X NIH FSH-S13) than eLH. It behaved like a LH molecule in DES-primed granulosa cells, but did show activity (approximately 1 X NIH FSH-S13) in stimulating the production of plasminogen activator and progesterone in eCG-primed granulosa cells. From these results, we conclude that under our culture conditions, neither eLH nor eCG was active in the DES-primed granulosa cells, but both were active in the eCG-primed cells, and that the choice of assay conditions and reference standards is very important. Different types of assay may give rise to completely different comparisons for the same molecules. The equine gonadotropins provide a particularly dramatic example of such differences.
通过三种检测方法,对马促卵泡素(eFSH)、马促黄体素(eLH)、马绒毛膜促性腺激素(eCG)和羊促黄体素(oLH)中的促卵泡素活性进行了检测,并与标准参考制剂美国国立卫生研究院促卵泡素-S13(NIH FSH-S13)中的活性进行了比较:采用大鼠睾丸匀浆的促卵泡素放射受体检测法,以及检测己烯雌酚(DES)或eCG预处理的供体大鼠颗粒细胞中纤溶酶原激活物生成和类固醇生成活性的方法。两种颗粒细胞的差异在于,经eCG预处理的细胞已具有显著的芳香化酶活性。在这三种检测中,除oLH显示出极低的促卵泡素活性(约为NIH FSH-S13的0.03 - 0.08倍)外,马促性腺激素在每种检测中的活性表现出很大差异。在这些检测中活性最高的分子eFSH,在受体结合检测中活性为44倍NIH FSH-S13,在纤溶酶原激活物生成检测中为8.75倍NIH FSH-S13,在DES预处理的颗粒细胞中进行类固醇生成检测时为4 - 5倍NIH FSH-S13。在经eCG预处理的细胞中,eFSH在纤溶酶原激活物生成检测中的活性为4.2倍NIH FSH-S13,在孕酮生成检测中为8.2倍NIH FSH-S13。eLH在促卵泡素放射受体检测中的活性为10倍NIH FSH-S13,但在刺激DES预处理的颗粒细胞的细胞反应中活性极低,表现与oLH相似。然而,当在经eCG预处理的细胞中检测eLH时,它在纤溶酶原激活物和孕酮生成方面确实显示出刺激活性;然而,剂量反应曲线与eFSH和eCG的曲线不平行。eCG的促卵泡素受体结合活性(0.29倍NIH FSH-S13)远低于eLH。在DES预处理的颗粒细胞中它表现得像促黄体素分子,但在刺激经eCG预处理的颗粒细胞中纤溶酶原激活物和孕酮生成方面确实显示出活性(约为1倍NIH FSH-S13)。从这些结果中,我们得出结论,在我们的培养条件下,eLH和eCG在DES预处理的颗粒细胞中均无活性,但在经eCG预处理的细胞中均有活性,并且检测条件和参考标准的选择非常重要。不同类型的检测可能会对相同分子产生完全不同的比较结果。马促性腺激素就是这种差异的一个特别显著的例子。